Nizatidine
Composition
This formulation contain Nizatidine as active agent
Indications
primarily indicated for the treatment of peptic ulcer disease, including duodenal ulcers, gastric ulcers, and erosive esophagitis
Side effects
headache, dizziness, fatigue, diarrhea, and constipatio
Precautions
Patients should avoid alcohol and certain Formulations while taking nizatidine.
Contraindications
contraindicated in patients with a known hypersensitivity to the drug or any of its components.
Dosage and administration
directed by a healthcare professional
Countries
Available Forms
Tablet
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai